Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony. | ScholarDeck

Paper

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

New research · Ophthalmology

Case reports in ophthalmological medicine · 1mo

StudyCase reports in ophthalmological medicine· 2026

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

Dan Spiegelman, Isabella Song, Erin Sieck

Read paper

UveitisStudyTreatment

Suprachoroidal triamcinolone raised dangerously low eye pressure in one uveitis case.

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

Dan Spiegelman … Erin Sieck

Case reports in ophthalmological medicine · 2026

Purpose

This study is aimed at describing the use of suprachoroidal triamcinolone injection for the treatment of refractory uveitis-associated ocular hypotony presumed secondary to ciliary body shutdown.

Methods

We report a case of a 58-year-old woman with a 26-year history of idiopathic, noninfectious bilateral panuveitis complicated by recurrent cystoid macular edema and a steroid-induced ocular hypertension.

Results

≥ 6 mmHg

Eye pressure rose from 2-6 mmHg to at least 6 mmHg for about 2 months after injection.

More results

Best corrected visual acuity improved from 20/80 to 20/50, and additional viscoelastic injections were not required during this period.

Numerical hypotony recurred 8 months later.

“

Conclusion · 1 of 2

Suprachoroidal triamcinolone may represent a targeted treatment for refractory uveitis-associated hypotony when ciliary body dysfunction is suspected and other steroid delivery routes are limited.

Conclusion · 2 of 2

Further study is needed to evaluate durability and broader applicability.

Read paper